제닉
Financials
Valuation Metrics
제닉's Market Cap is ₩1281B. At end of 2025 it was ₩1316B. Ranked #1064 of 2,405 in KR market (top 44%), #545 of 1,627 on KOSDAQ (top 33%), #24 of 56 in Household & Personal Products (top 43%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 128.06B KRW | KR#1,064/2,405 Sec#24/56 |
| Revenue | 114.29B KRW | KR#1,340/2,405 Sec#29/56 |
| Net Income | 26.06B KRW | KR#604/2,405 Sec#17/56 |
| Total Assets | 90.92B KRW | KR#1,853/2,405 Sec#38/56 |
| Net Assets | 55.79B KRW | KR#1,829/2,405 Sec#40/56 |
| Employees | 356 | KR#683/2,405 Sec#14/56 |
| Value | ||
| P/E | 4.91x | KR#394/2,405 Sec#6/56 |
| P/B | 2.30x | KR#2,042/2,405 Sec#48/56 |
| PEG | 0.07x | KR#358/2,405 Sec#10/56 |
| P/S | 1.12x | KR#1,510/2,405 Sec#39/56 |
| EV/EBITDA | 6.65x | KR#400/2,405 Sec#7/56 |
| FCF Yield | 14.04% | KR#515/2,405 Sec#5/56 |
| Profitability | ||
| ROE | 46.72% | KR#16/2,405 Sec#3/56 |
| ROA | 28.67% | KR#20/2,405 Sec#3/56 |
| Op. Margin | 16.76% | KR#240/2,405 Sec#5/56 |
| Revenue Growth | 48.33% | KR#219/2,405 Sec#6/56 |
| Earnings Growth | 74.70% | KR#454/2,405 Sec#15/56 |
| Financial Health | ||
| Debt Ratio | 62.97% | KR#1,128/2,405 Sec#31/56 |
| Total Debt | 3.00B KRW | KR#1,850/2,405 Sec#42/56 |
| FCF | 17.98B KRW | KR#546/2,405 Sec#13/56 |
| Cash | 3.66B KRW | KR#2,109/2,405 Sec#48/56 |
| Current Ratio | 1.83x | KR#954/2,405 Sec#26/56 |
| Net Debt/EBITDA | -0.03x | KR#599/2,405 Sec#19/56 |
| Performance | ||
| 1Y Return | -25.26% | KR#1,456/2,405 Sec#31/56 |
| 1M Return | -25.94% | KR#2,121/2,405 Sec#53/56 |
| From 52W High | -58.69% | KR#1,597/2,405 Sec#40/56 |
| 1Y MDD | -58.08% | KR#1,322/2,405 Sec#39/56 |
| Trading | ||
| Volume | 49,428 shares | KR#975/2,405 Sec#18/56 |
| Trading Value | 779.1M KRW | KR#659/2,405 Sec#12/56 |
| Foreign Own. | 4.20% | KR#1,000/2,405 Sec#18/56 |
| Per Share | ||
| EPS | 3,271 KRW | KR#318/2,405 Sec#9/56 |
| BPS | 7,001 KRW | KR#1,252/2,405 Sec#25/56 |
Company Info
Established in 2001 for the research, development, manufacturing, and sale of cosmetics and pharmaceuticals, the company was listed on KOSDAQ in 2011 and owns a wholly-owned sales corporation in China. Its core business revolves around R&D, manufacturing, and sales, leveraging its globally patented hydrogel technology. The company's brands are distributed through diverse channels, with online sales boosted by social media and influencer marketing. Increased product development and production requests reflect the acquisition of CGMP and various international certifications. Genic is headquartered in Seongnam-si, Gyeonggi-do.